TrialMolecular psychiatry2025

Treatment effect and safety of seltorexant as monotherapy for patients with major depressive disorder: a randomized, placebo-controlled clinical trial.

Sofie Mesens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.